Abstract
AbstractViruses are vulnerable as they transmit between hosts and we aimed to exploit this critical window. We found that the ubiquitous, safe, inexpensive and biodegradable small molecule propylene glycol (PG) has robust virucidal activity. Propylene glycol rapidly inactivates influenza, SARS-CoV-2 and a broad range of other enveloped viruses, and reduces disease burden in mice when administered intranasally at concentrations commonly found in nasal sprays. Most critically, aerosolized PG efficiently abolishes influenza and SARS-CoV-2 infectivity within airborne droplets, potently preventing infection at levels significantly below those well-tolerated by mammals. We present PG vapor as a first-in-class non-toxic airborne virucide, to prevent transmission of existing and emergent viral pathogens, with clear and immediate implications for public health.One-sentence summaryPropylene glycol is a potent and safe virucidal compound that could be used to limit and control infections.
Publisher
Cold Spring Harbor Laboratory
Reference65 articles.
1. World Health Organization, WHO Coronavirus (COVID-19) Dashboard (2022) (available at https://covid19.who.int).
2. World Health Organization, Global Influenza Programme - Burden of Disease (2022) (available at https://www.who.int/teams/global-influenza-programme/surveillance-and-monitoring/burden-of-disease).
3. National Engineering Policy Centre, Infection resilient environments: time for a major upgrade (2022).
4. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
5. Public health measures for covid-19